LEE A L Z ET AL: "The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 30, no. 5, 1 February 2009 (2009-02-01), pages 919-927, XP025801486, ISSN: 0142-9612, DOI: 10.1016/J.BIOMATERIALS.2008.10.062 [retrieved on 2008-11-29] (B1)

P. Boasberg ET AL: "Nab-paclitaxel and bevacizumab as first-line therapy in patients with unresectable stage III and IV melanoma", http://meetinglibrary.asco.org, 1 January 2009 (2009-01-01), pages 1-2, XP055155824, Retrieved from the Internet: URL:http://meetinglibrary.asco.org/print/5 84876 [retrieved on 2014-11-28] (B1)

WAGNER S ET AL: "Enhanced drug targeting by attachment of an anti alphav integrin antibody to doxorubicin loaded human serum albumin nanoparticles", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 31, no. 8, 1 March 2010 (2010-03-01), pages 2388-2398, XP026870608, ISSN: 0142-9612 [retrieved on 2010-01-22] (B1)

US-A1- 2010 112 077 (B1)

PARKER EDWARD ET AL: "Targeting CLL Cells Using Rituximab-Conjugated Surface Enhanced Raman Scattering (SERS) Gold Nanoparticles", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 116, no. 21, 1 November 2010 (2010-11-01), page 1109, XP009173630, ISSN: 0006-4971 (B1)